¹ú²ú³Ô¹Ï

SeQuent Scientific Ltd is a leading player in the global animal healthcare sector, specializing in manufacturing and marketing veterinary pharmaceuticals. With a strong focus on developing high-quality products, the company serves various international markets. SeQuent is known for its expertise in Active Pharmaceutical Ingredients (APIs) and formulations for animal health, contributing to its growing presence in the industry. SeQuent Share Price on NSE as of 27 September 2024 is 215.00 INR. Here are more details on SeQuent Share Price Target 2024, 2025, 2026 to 2030.

SeQuent Scientific Ltd: Market Overview

• Open Price: ₹194.00
• High Price: ₹224.68
• Low Price: ₹192.86
• Previous Close: ₹191.43
• Volume: 59,058,970
• VWAP: 213.21
• UC Limit: ₹229.71
• LC Limit: ₹153.14
• P/E ratio: 1,006.27
• Div yield: N/A
• 52-wk high: ₹224.68
• 52-wk low: ₹90.00
• Mkt cap: ₹5.45KCr
• Face Value: ₹2

SeQuent Share Price Today Chart

SeQuent Share Price Target Tomorrow 2024 To 2030

SeQuent Share Price Target 2024

SeQuent share price target 2024 Expected target could be ₹240. Here are three key factors affecting SeQuent Scientific Ltd’s share price target growth for 2024:

1. Expansion into Global Markets: SeQuent’s strategy to expand its footprint in international markets can significantly boost its revenue. By increasing its presence in regions with growing demand for veterinary pharmaceuticals, the company can enhance its market share and drive share price growth.
2. Innovation in Product Development: Continuous investment in research and development to create innovative veterinary products will strengthen SeQuent’s competitive advantage. Successful launches of new products can attract more customers and increase sales, positively impacting share prices.

3. Regulatory Approvals and Compliance: Obtaining necessary regulatory approvals for its products is crucial for SeQuent. Any delays or challenges in compliance can hinder growth. Conversely, timely approvals will enable the company to bring products to market faster, enhancing investor confidence and potentially boosting the share price.

SeQuent Share Price Target 2025

SeQuent share price target 2025 Expected target could be ₹360. Here are three key factors affecting SeQuent Scientific Ltd’s share price target growth for 2025:

1. Strategic Acquisitions: SeQuent’s potential for growth through strategic acquisitions in the veterinary pharmaceutical sector can enhance its product portfolio and market presence. Successful integration of acquired companies can lead to increased revenue streams and improved profitability, positively influencing the share price.
2. Sustainable Practices and ESG Initiatives: Growing emphasis on sustainability and corporate social responsibility can affect SeQuent’s reputation and investor appeal. By implementing eco-friendly practices and adhering to Environmental, Social, and Governance (ESG) criteria, the company can attract socially conscious investors, leading to higher share prices.

3. Market Demand for Veterinary Products: The increasing awareness of pet health and the rising demand for veterinary medicines will likely contribute to SeQuent’s revenue growth. As more consumers prioritize animal health and welfare, the company’s ability to meet this demand will play a crucial role in its share price performance in 2025.

SeQuent Share Price Target 2030

SeQuent share price target 2030 Expected target could be ₹1012. Here are three key factors affecting SeQuent Scientific Ltd’s share price target growth for 2030:

1. Global Expansion: SeQuent’s efforts to expand its operations into new international markets can significantly enhance its growth potential. By establishing a strong presence in emerging markets, the company can tap into new customer bases, which may lead to increased revenue and a higher share price by 2030.
2. Innovative Product Development: Continuous investment in research and development (R&D) for innovative veterinary pharmaceuticals and nutraceuticals will be crucial. The successful launch of new and effective products can strengthen SeQuent’s market position, attract more customers, and ultimately drive share price growth.

3. Regulatory Compliance and Quality Assurance: Adhering to stringent regulatory standards and maintaining high quality in its products are vital for SeQuent’s reputation and operational success. A strong track record in compliance can build investor confidence, leading to sustained growth in share price as the company demonstrates reliability and safety in its offerings.

Shareholding Pattern For SeQuent Scientific Ltd

• Promoters: 52.78%
• Foreign Institutions:Ìý5.70%
• Mutual Funds: 33.46%
• Domestic Institutions: 8.06%

SeQuent Scientific Ltd Financial

Read Also:- Stock Market Update- Kamopaints Share Price Target Tomorrow 2024 To 2030